Market Tracker

01/23 6:05pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

5.41
Data as of Jan 23
 +0.13 / +2.46%
Today’s Change
3.11
Today|||52-Week Range
7.82
-10.73%
Year-to-Date

Today’s Trading

Previous close5.28
Today’s open5.45
Day’s range5.32 - 5.68
Volume5,406,279
Average volume (3 months)3,141,286
Market cap$666.3M
Dividend yield--
Data as of 4:00pm ET, 01/23/2015

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+91.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book13.57

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc+0.13+3.13%
OMEDOncoMed Pharmaceutic...-0.31-1.36%
SCMPSucampo Pharmaceutic...-0.25-1.62%
EPZMEpizyme Inc+0.51+2.60%
Data as of 4:14pm ET, 01/23/2015

Financials

Next reporting dateMarch 11, 2015
EPS forecast (this quarter)$0.00
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts